ToxicoloGee Whiz, PhD

@toxicologee.bsky.social

Bioinformatics PhD, cheminformatics, data scientist, statistics, toxicology and coding at Eli Lilly... I do it all! Currently focused in off-target ID for genetic medicines. Mom to a kid and a cat. Thoughts and opinions are my own

Currently, there's a lot of interest in quantitative models that would help us understand and predict features of the complex cellular systems that underlie human health and disease - think about virtual cells, for example. On can trace some of these ideas back to the early days of systems biology.

Nature Reviews Genetics@natrevgenet.nature.com · last yr.

Adapting systems biology to address the complexity of human disease in the single-cell era go.nature.com/3XBo6Vh #Review by @davidsebfischer.bsky.social, Martin A. Villanueva, Peter S. Winter & Alex K. Shalek @broadinstitute.org @mitofficial.bsky.social @ragoninstitute.bsky.social

PLOS has issued a statement on recent US Executive Orders and scientific integrity. We are determined to stand firmly behind our mission, our values and our principles, and against any attempt at censorship or undermining of the core principles of scientific inquiry. plos.io/3D4O8cH

PLOS statement on recent US Executive Orders and scientific integrity - The Official PLOS Blog

Since its founding over twenty five years ago PLOS has been dedicated to advancing open science, ensuring that knowledge is accessible to…

plos.io

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine had no signs of relapse after three years. Dr. Vinod Balachandran from @mskcancercenter.bsky.social joins us to discuss the results and what they could mean for cancer treatment.

A Vaccine For Pancreatic Cancer Continues To Show Promise

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.

buff.ly

I have big news: @ellis.eu has launched its 2nd major research center, @ellisfinland.bsky.social! I have agreed to start as founding director & the first call for PI positions is open. This is a major opportunity for outstanding researchers, join us! ellisinstitute.fi/PI-recruit

Principal Investigator positions at ELLIS Institute Finland | ELLIS Institute Finland

Now recruiting new PIs in artificial intelligence and machine learning

ellisinstitute.fi

🚨 PhD in Bioinformatics & Gene Regulation 🚨 Join the Bioinformatics in Life Science (BiLS) initiative through a multidisciplinary project to unravel gene regulation from DNA to proteins, co-supervised by E. Valen @jonnings.bsky.social and me! www.jobbnorge.no/en/available...

PhD Research Fellow in Bioinformatics and Gene Regulation (274506) | University of Oslo

Job title: PhD Research Fellow in Bioinformatics and Gene Regulation (274506), Employer: University of Oslo, Deadline: Friday, February 28, 2025

jobbnorge.no

Modern GWAS can identify 1000s of significant hits but it can be hard to turn this into biological insight. What key cellular functions link genetic variation to disease? I'm very excited to present our new work combining associations and Perturb-seq to build interpretable causal graphs! A 🧵

Bild

We are hiring! We have a fully-funded 2-year T32 post-doc slot to study spatial biology in lung regeneration. Background in data visualization useful but not required. If you’re interested or know of anyone, please get in touch or pass along! RaredonLab.com Description & teasers attached:

BildBildBildBild

📣 We are hiring! Join Yoshiji Lab at McGill University Dept of Human Genetics in Montreal, Canada! yoshiji-lab.org/joinus ✅Fully Funded Positions • 2 MSc Students • 1 PhD Student • 1 Postdoc ✅Goal: Using human genetics and multi-omics for drug target discovery and precision medicine

BildBild
Satoshi Yoshiji, MD, PhD@satoshiyoshiji.bsky.social · 2y ago

📣Excited to share our paper in Nature Genetics! rdcu.be/d7mo0 Do plasma proteins mediate obesity’s effect on CAD risk? →Using two-step proteome-wide MR, domain-aware MR, epigenomics & scRNA-seq, we prioritized endotrophin, cleaved from COL6A3, as a mediator & potential therapeutic target. A 🧵↓

RNA gene therapies offer hope for millions with high cholesterol "Base editing, antisense oligonucleotides and siRNA therapies that target low-density lipoprotein and the genes encoding molecules that regulate it are being tested in several clinical trials." www.nature.com/articles/d41...

RNA gene therapies offer hope for millions with high cholesterol

Base editing, antisense oligonucleotides and siRNA therapies that target low-density lipoprotein and the genes encoding molecules that regulate it are being tested in several clinical trials.

nature.com